Y-Intercept (HK)’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $546K | Buy |
+6,586
| New | +$546K | 0.01% | 1176 |
|
|
2024
Q3 | – | Sell |
-9,083
| Closed | -$842K | – | 1872 |
|
|
2024
Q2 | $842K | Buy |
9,083
+392
| +5% | +$36.3K | 0.05% | 571 |
|
|
2024
Q1 | $825K | Buy |
+8,691
| New | +$825K | 0.06% | 466 |
|
|
2023
Q1 | – | Sell |
-3,222
| Closed | -$267K | – | 1592 |
|
|
2022
Q4 | $267K | Sell |
3,222
-1,283
| -28% | -$106K | 0.04% | 713 |
|
|
2022
Q3 | $357K | Buy |
+4,505
| New | +$357K | 0.04% | 644 |
|
|
2021
Q2 | – | Sell |
-7,351
| Closed | -$956K | – | 948 |
|
|
2021
Q1 | $956K | Buy |
+7,351
| New | +$956K | 0.26% | 105 |
|